Active 0 6 0 6 B-chronic_disease
choroidal 7 16 7 16 I-chronic_disease
neovascularization 17 35 17 35 I-chronic_disease
( 36 37 36 37 I-chronic_disease
CNV 37 40 37 40 I-chronic_disease
) 40 41 40 41 I-chronic_disease
due 42 45 42 45 O
to 46 48 46 48 O
AMD 49 52 49 52 B-chronic_disease

Any 0 3 53 56 O
contraindication 4 20 57 73 O
for 21 24 74 77 O
topical 25 32 78 85 O
use 33 36 86 89 O
of 37 39 90 92 O
a 40 41 93 94 O
beta 42 46 95 99 B-treatment
- 46 47 99 100 I-treatment
blocker 47 54 100 107 I-treatment
( 55 56 108 109 O
e.g. 56 60 109 113 O
, 60 61 113 114 O
bradycardia 62 73 115 126 B-chronic_disease
, 73 74 126 127 O
decompensated 75 88 128 141 B-chronic_disease
heart 89 94 142 147 I-chronic_disease
failure 95 102 148 155 I-chronic_disease
, 102 103 155 156 O
chronic 104 111 157 164 B-chronic_disease
obstructive 112 123 165 176 I-chronic_disease
pulmonary 124 133 177 186 I-chronic_disease
disease 134 141 187 194 I-chronic_disease
, 141 142 194 195 O
reactive 143 151 196 204 B-chronic_disease
airway 152 158 205 211 I-chronic_disease
disease 159 166 212 219 I-chronic_disease
, 166 167 219 220 O
asthma 168 174 221 227 B-chronic_disease
, 174 175 227 228 O
etc 176 179 229 232 O
. 179 180 232 233 O
) 180 181 233 234 O

Any 0 3 235 238 O
history 4 11 239 246 O
of 12 14 247 249 O
vitrectomy 15 25 250 260 B-treatment
or 26 28 261 263 O
glaucoma 29 37 264 272 B-treatment
surgery 38 45 273 280 I-treatment
( 46 47 281 282 O
e.g. 47 51 282 286 O
, 51 52 286 287 O
trabeculectomy 53 67 288 302 B-treatment
, 67 68 302 303 O
tube 69 73 304 308 B-treatment
shunt 74 79 309 314 I-treatment
) 79 80 314 315 O

Any 0 3 316 319 O
ophthalmic 4 14 320 330 B-treatment
surgery 15 22 331 338 I-treatment
within 23 29 339 345 O
previous 30 38 346 354 B-upper_bound
6 39 40 355 356 I-upper_bound
months 41 47 357 363 I-upper_bound
, 47 48 363 364 O
including 49 58 365 374 O
cataract 59 67 375 383 B-treatment
extraction 68 78 384 394 I-treatment

Baseline 0 8 395 403 B-clinical_variable
CST 9 12 404 407 I-clinical_variable
≥ 13 14 408 409 O
270 15 18 410 413 B-lower_bound
µm 19 21 414 416 I-lower_bound
on 22 24 417 419 O
SD 25 27 420 422 O
- 27 28 422 423 O
OCT 28 31 423 426 O
automated 32 41 427 436 O
retinal 42 49 437 444 O
thickness 50 59 445 454 O
map 60 63 455 458 O

Current 0 7 459 466 O
prescription 8 20 467 479 O
eye 21 24 480 483 O
drop 25 29 484 488 O
usage 30 35 489 494 O
( 36 37 495 496 O
e.g. 37 41 496 500 O
, 41 42 500 501 O
glaucoma 43 51 502 510 B-treatment
drops 52 57 511 516 I-treatment
, 57 58 516 517 O
corticosteroid 59 73 518 532 B-treatment
drops 74 79 533 538 I-treatment
, 79 80 538 539 O
etc 81 84 540 543 O
. 84 85 543 544 O
) 85 86 544 545 O

Prior 0 5 546 551 B-treatment
treatment 6 15 552 561 I-treatment
with 16 20 562 566 O
at 21 23 567 569 O
least 24 29 570 575 O
4 30 31 576 577 B-lower_bound
injections 32 42 578 588 O
of 43 45 589 591 O
anti 46 50 592 596 B-treatment
- 50 51 596 597 I-treatment
VEGF 51 55 597 601 I-treatment
agents 56 62 602 608 I-treatment
in 63 65 609 611 O
the 66 69 612 615 O
past 70 74 616 620 B-upper_bound
6 75 76 621 622 I-upper_bound
months 77 83 623 629 I-upper_bound
and 84 87 630 633 O
persistent 88 98 634 644 O
intraretinal 99 111 645 657 O
and/or 112 118 658 664 O
subretinal 119 129 665 675 O
fluid 130 135 676 681 O
on 136 138 682 684 O
SD 139 141 685 687 O
- 141 142 687 688 O
OCT 142 145 688 691 O
at 146 148 692 694 O
each 149 153 695 699 O
visit 154 159 700 705 O
during 160 166 706 712 O
this 167 171 713 717 O
period 172 178 718 724 O

Subjects 0 8 725 733 O
of 9 11 734 736 O
either 12 18 737 743 O
gender 19 25 744 750 O
aged 26 30 751 755 B-age
≥ 31 32 756 757 O
45 33 35 758 760 B-lower_bound
years 36 41 761 766 I-lower_bound

Time 0 4 767 771 O
interval 5 13 772 780 O
of 14 16 781 783 O
5 17 18 784 785 O
weeks 19 24 786 791 O
( 25 26 792 793 O
± 26 27 793 794 O
1 28 29 795 796 O
week 30 34 797 801 O
) 34 35 801 802 O
between 36 43 803 810 O
visits 44 50 811 817 O
for 51 54 818 821 O
at 55 57 822 824 O
least 58 63 825 830 O
two 64 67 831 834 B-lower_bound
visits 68 74 835 841 O
immediately 75 86 842 853 O
preceding 87 96 854 863 O
study 97 102 864 869 O
enrollment 103 113 870 880 O

